Client
- Name
- LUNDBECK LLC
- Location
- District of Columbia · United States of America
Registrant
- Firm
- LUNDBECK LLC
- Description
- Specialty and Central Nervous System Bio-pharmaceutical manufacturing
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues pertaining to Pharmacy Benefit Managers Drug Affordability - H.R. 830, S. 1375 - the HELP Copays Act Step therapy reform - S. 6452 & H.R. 2630 - the Safe Step Act Neuroscience Drug Program - FY 2025 AgFDA Approps BRAIN Initiative - FY 2025 Labor-HHS Appropriations Migraine care - FY 2025 MilCon Approps Chronic Pain Research - H.R. 7164 Advancing Research for Chronic Pain Act; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act BOLD Infrastructure for Alzheimers Reauthorization Act - H.R. 7218, S. 3775
LobbyistsHEATHER STRAWN · HAYLEY ALEXANDER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues pertaining to the 340B Drug Discount Program - H.R. 8574 340B ACCESS Act Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC Alzheimers screening in Medicare - S. 2379 & H.R. 4752 - The Change Act of 2023 Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2025 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 5539 & S. 3131 - The ORPHAN Cures Act of 2023 Small molecule discrepancy in the Inflation Reduction Act - H.R. 7174 - The EPIC Act
LobbyistsHEATHER STRAWN · HAYLEY ALEXANDER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
